| Gene symbol | FLT3LG | Synonyms | FL, FLG3L, FLT3L | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.33 | dbXrefs | |
| Description | fms related receptor tyrosine kinase 3 ligand | ||||
| GTO ID | GTC2981 |
| Trial ID | NCT05312411 |
| Disease | Osteosarcoma |
| Altered gene | FL |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | SCRI-E2CAR_EGFRtv1 |
| Co-treatment | UB-TT170 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma |
| Year | 2022 |
| Country | United States |
| Company sponsor | Seattle Children's Hospital |
| Other ID(s) | ENLIGHTen-01 |
| Cohort 1 | |||||||||||
|
|||||||||||